What is vyvanse

What is Vyvanse?

Vyvanse is a prescription-only stimulant medication used to treat attention-deficit/hyperactivity disorder (ADHD) and binge eating disorder. The active ingredient is lisdexamfetamine dimesylate, a compound that belongs to the class of medications known as sympathomimetic amines. Vyvanse is manufactured by Takeda Pharmaceutical and was approved by the FDA in 2007 for ADHD treatment.

How Vyvanse Works

Vyvanse is unique because it is a prodrug, meaning it is inactive until the body metabolizes it. After ingestion, lisdexamfetamine is converted by enzymes in red blood cells to dexamphetamine, the active form of the medication. This metabolism-dependent activation provides several advantages over other stimulant medications. It means the medication cannot be abused through routes other than oral administration, as non-oral routes would bypass the conversion process.

Once activated to dexamphetamine, the medication works by increasing the release of neurotransmitters called dopamine and norepinephrine in the brain. These neurotransmitters are involved in attention, impulse control, and executive function. By increasing their levels, Vyvanse helps improve focus, attention, and reduces impulsive behaviors characteristic of ADHD.

Uses and FDA Approval

Vyvanse is FDA-approved for treating ADHD in patients ages 6 years and older, including children, adolescents, and adults. For ADHD, Vyvanse helps improve attention and concentration while reducing hyperactivity and impulsive behaviors. It is also FDA-approved for treating moderate-to-severe binge eating disorder in adults. In binge eating disorder treatment, Vyvanse works by reducing the frequency and intensity of binge eating episodes.

Dosing and Administration

Vyvanse comes in capsule form with once-daily dosing. Capsules are available in various strengths, typically ranging from 10 mg to 70 mg. The medication is usually taken in the morning to avoid sleep disruption. Healthcare providers start patients on lower doses and titrate (gradually increase) the dose based on individual response and tolerance. Maximum recommended daily doses typically do not exceed 70 mg for ADHD and 70 mg for binge eating disorder, though dosing is individualized by prescribing physicians.

Side Effects and Safety

Common side effects of Vyvanse include decreased appetite, insomnia or sleep difficulties, increased heart rate, and elevated blood pressure. Some patients experience dry mouth, anxiety, or nervousness. More serious but less common side effects can include chest pain, severe headaches, or changes in mental health status. Vyvanse is not recommended for patients with certain heart conditions, and blood pressure and heart rate should be monitored during treatment.

Potential for Dependence

As a stimulant medication, Vyvanse carries a potential for physical and psychological dependence, particularly if misused or used at higher than prescribed doses. Patients should take Vyvanse exactly as prescribed by their healthcare provider and inform their provider about any personal or family history of substance abuse or addiction. Abrupt discontinuation should be avoided, and dosages should be adjusted under medical supervision.